JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB196984

Anti-IFNL4 antibody [51-1]

Be the first to review this product! Submit a review

|

(9 Publications)

Rabbit Recombinant Monoclonal IFNL4 antibody. Suitable for BL, WB and reacts with Human, Synthetic peptide samples. Cited in 9 publications.

View Alternative Names

Interferon lambda-4, IFN-lambda-4, IFNL4

4 Images
Blocking - Anti-IFNL4 antibody [51-1] (AB196984)
  • BL

Supplier Data

Blocking - Anti-IFNL4 antibody [51-1] (AB196984)

Stable inducible HepG2-IFN-λ4-ISRE-Luc cells were induced with 0.5 mg/ml doxycycline for 16hours and then treated with PBS (negative control) and rabbit IgG (20μg/ml) for 22 hours and assayed for luciferase expression. α-IFN-λ4 (ab196984) blocks the ability of IFN-λ4 to induce of ISRE-Luc reporter by 70%.

This image was generated from the hybridoma version of the product.

This image is courtesy of Ludmila Prokunina-Olsson

Western blot - Anti-IFNL4 antibody [51-1] (AB196984)
  • WB

Supplier Data

Western blot - Anti-IFNL4 antibody [51-1] (AB196984)

Prokunina-Olsson, NG, 2013 and Onabajo et al, JICR, 2015

This image was generated from the hybridoma version of the product.

All lanes:

Western blot - Anti-IFNL4 antibody [51-1] (ab196984) at 1/1500 dilution

Lane 1:

Recombinant Interferon lambda 4 protein (250 ng)

Lane 2:

Recombinant Interferon lambda 4 protein (50 ng)

Predicted band size: 20 kDa

false

This image is courtesy of Ludmila Prokunina-Olsson

Western blot - Anti-IFNL4 antibody [51-1] (AB196984)
  • WB

Unknown

Western blot - Anti-IFNL4 antibody [51-1] (AB196984)

Blocking and dilution buffer : 5% NFDM/TBST.

The observed size is larger (50 kDa for IFNL4-Halo than the predicted size because of the Halo-tag.

All lanes:

Western blot - Anti-IFNL4 antibody [51-1] (ab196984) at 1/1000 dilution

Lane 1:

Empty vector transfected HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg

Lane 2:

HepG2 transfected with Halo-tagged IFNL4, whole cell lysate

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 20 kDa

false

Western blot - Anti-IFNL4 antibody [51-1] (AB196984)
  • WB

CiteAb

Western blot - Anti-IFNL4 antibody [51-1] (AB196984)

IFNL4 western blot using anti-IFNL4 antibody [51-1] ab196984. Publication image and figure legend from Sung, P. S., Hong, S. H., et al., 2017, Sci Rep, PubMed 28630501.

ab196984 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab196984 please see the product overview.

IFN-λ4 overexpression induces ISG expression. (A,B) Huh-7 cells were transfected with control or IFN-λ4-expressing plasmids. After 72 hours, the cell lysates (A) and culture supernatants (B) were harvested, and protein expression were analysed by immunoblot. For the culture supernatants, immunoprecipitation with anti-FLAG-conjugated beads were used to pull down the FLAG-tagged IFN-λ4 protein. The data are representative of two independent experiments. (C,D) Huh-7 cells were transfected with control, IFN-λ1-, IFN-λ4-, or IFN-β-expressing plasmids. After 96 hours, the cells were harvested, and protein expression or gene expression were analysed by immunoblot (C) or real-time qPCR (D). (E) Huh-7 cells were transfected with IFN-λ4-expressing plasmids. The cells were harvested at the indicated time points, and gene expression was analysed by real-time qPCR. (F) Huh-7 cells were infected with JFH1 HCVcc at 0.5 MOI followed by transfection with control or IFN-λ4-expressing plasmids. After 72 hours, the cells were harvested, and HCV RNA titer was analysed by real-time qPCR. (G,H) Huh-7 cells were transfected with control, IFN-λ4-, or IFN-λ4 TT-encoding plasmids. After 96 hours, the cells were harvested, and protein and gene expression were analysed by immunoblot (G) or real-time qPCR (H). In (D,E,F,H) data are presented as means ± S.E.M. ***P ≤ 0.001 (Student’s t-test). All the data are representative of two independent experiments. Full-length blots of PY-STAT1 (C) with multiple exposure times are included in the Supplementary Fig. 9C.

false

  • Carrier free

    Anti-IFNL4 antibody [51-1] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

51-1

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, BL

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "BL" : {"fullname" : "Blocking", "shortname":"BL"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "BL-species-checked": "testedAndGuaranteed", "BL-species-dilution-info": "", "BL-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-5 µg/mL", "WB-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Synthetic peptide": { "BL-species-checked": "notRecommended", "BL-species-dilution-info": "", "BL-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-5 µg/mL", "WB-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

This product has switched from a hybridoma to recombinant production method on 6th January 2021.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.01% Sodium azide Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

IFNL4 also known as Interferon Lambda 4 plays an important role in the immune system. This protein with a mass of approximately 22 kDa is part of the type III interferon family. It expresses mainly in liver cells and epithelial tissues. IFNL4 is involved in the antiviral defense mechanism of the body. It shows activity by binding to the IFN lambda receptor complex initiating a response that helps control viral infections.
Biological function summary

IFNL4 acts as a cytokine and contributes to modulating immune responses. It is not part of a complex but interacts closely with the IFN lambda receptor to activate Janus kinase and signal transducer and activator of transcription (JAK-STAT) signaling pathways. This activation leads to the promotion of antiviral responses in infected cells and limits viral spread. Understanding its signaling function clarifies its important impact on immune defense.

Pathways

IFNL4 is fundamental to the JAK-STAT signaling pathway and to the innate immune response pathway. These pathways mediate cellular responses to viral infections. IFNL4 interacts with other proteins like IFNLR1 IL10RB and STAT1 which are essential for these pathways. By engaging these pathways IFNL4 helps control the expression of genes involved in antiviral defense such as those coding for interferon-stimulated genes (ISGs).

IFNL4 has strong connections to hepatitis C virus (HCV) infection and liver fibrosis. Researchers found that the expression of IFNL4 can influence the outcome of HCV infection affecting viral clearance and treatment response. Another related protein IFNL3 also interacts with these pathways and together they provide insights into the genetic factors influencing liver fibrosis progression. Understanding IFNL4's role provides opportunities to develop targeted therapies for these conditions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Cytokine that may trigger an antiviral response activating the JAK-STAT pathway and up-regulating specifically some interferon-stimulated genes.
See full target information IFNL4

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in immunology 12:692263 PubMed34497603

2021

Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects.

Applications

Unspecified application

Species

Unspecified reactive species

Olusegun O Onabajo,Fang Wang,Mei-Hsuan Lee,Oscar Florez-Vargas,Adeola Obajemu,Chizu Tanikawa,Joselin M Vargas,Shu-Fen Liao,Ci Song,Yu-Han Huang,Chen-Yang Shen,A Rouf Banday,Thomas R O'Brien,Zhibin Hu,Koichi Matsuda,Ludmila Prokunina-Olsson

Cytokine 125:154833 PubMed31479875

2019

Structure-based glycoengineering of interferon lambda 4 enhances its productivity and anti-viral potency.

Applications

Unspecified application

Species

Unspecified reactive species

Jae-Hee Chung,Seon-Hui Hong,Nari Seo,Tae-Shin Kim,Hyun Joo An,Pedro Lee,Eui-Cheol Shin,Ho Min Kim

Communications biology 1:191 PubMed30456312

2018

-ΔG is associated with prostate cancer among men at increased risk of sexually transmitted infections.

Applications

WB

Species

Human

Tsion Zewdu Minas,Wei Tang,Cheryl J Smith,Olusegun O Onabajo,Adeola Obajemu,Tiffany H Dorsey,Symone V Jordan,Obadi M Obadi,Bríd M Ryan,Ludmila Prokunina-Olsson,Christopher A Loffredo,Stefan Ambs

Clinical cancer research : an official journal of 24:5471-5481 PubMed30012562

2018

-ΔG Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer.

Applications

BL

Species

Human

Wei Tang,Tiffany A Wallace,Ming Yi,Cristina Magi-Galluzzi,Tiffany H Dorsey,Olusegun O Onabajo,Adeola Obajemu,Symone V Jordan,Christopher A Loffredo,Robert M Stephens,Robert H Silverman,George R Stark,Eric A Klein,Ludmila Prokunina-Olsson,Stefan Ambs

Journal of immunology (Baltimore, Md. : 1950) 199:3808-3820 PubMed29070670

2017

IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling.

Applications

WB

Species

Human

Adeola A Obajemu,Nina Rao,Kari A Dilley,Joselin M Vargas,Faruk Sheikh,Raymond P Donnelly,Reed S Shabman,Eric G Meissner,Ludmila Prokunina-Olsson,Olusegun O Onabajo

Scientific reports 7:3821 PubMed28630501

2017

IFN-λ4 potently blocks IFN-α signalling by ISG15 and USP18 in hepatitis C virus infection.

Applications

WB

Species

Human

Pil Soo Sung,Seon-Hui Hong,Jae-Hee Chung,Sojeong Kim,Su-Hyung Park,Ho Min Kim,Seung Kew Yoon,Eui-Cheol Shin

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 36:30-6 PubMed26308395

2015

Comparative Functional Analysis of 12 Mammalian IFN-λ4 Orthologs.

Applications

WB

Species

Human

Ashley Paquin,Olusegun O Onabajo,Wei Tang,Ludmila Prokunina-Olsson

Journal of interferon & cytokine research : the of 35:888-900 PubMed26134097

2015

Expression of Interferon Lambda 4 Is Associated with Reduced Proliferation and Increased Cell Death in Human Hepatic Cells.

Applications

BL, WB

Species

Human, Human

Olusegun O Onabajo,Patricia Porter-Gill,Ashley Paquin,Nina Rao,Luyang Liu,Wei Tang,Nathan Brand,Ludmila Prokunina-Olsson

Nature genetics 45:164-71 PubMed23291588

2013

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.

Applications

WB

Species

Human

Ludmila Prokunina-Olsson,Brian Muchmore,Wei Tang,Ruth M Pfeiffer,Heiyoung Park,Harold Dickensheets,Dianna Hergott,Patricia Porter-Gill,Adam Mumy,Indu Kohaar,Sabrina Chen,Nathan Brand,McAnthony Tarway,Luyang Liu,Faruk Sheikh,Jacquie Astemborski,Herbert L Bonkovsky,Brian R Edlin,Charles D Howell,Timothy R Morgan,David L Thomas,Barbara Rehermann,Raymond P Donnelly,Thomas R O'Brien
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com